Australia Stock Exchange release from IMPEDIMED : AstraZeneca extends and increases Renal Contract
17/03/2022 23:23
Australia Stock Exchange release from IMPEDIMED IPD.AX : AstraZeneca extends and increases Renal Contract
- AU$14.64m
- AU$15.95m
- AU$14.61m